Drug intelligence / Profile preview

Folsmart

Development stage
Preclinical
Lead developer
SOLFARCOS
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intravenous
01

Overview

Folsmart is a targeted liposomal formulation of the small molecule antimetabolite methotrexate, developed by SOLFARCOS for the treatment of rheumatoid arthritis. The drug utilizes a targeted liposomal delivery system designed to selectively accumulate in inflamed synovial tissues, thereby increasing local therapeutic concentrations while minimizing the systemic toxicity typically associated with conventional methotrexate therapy. Methotrexate acts as a competitive inhibitor of the enzyme dihydrofolate reductase (DHFR), which is essential for the synthesis of purines and pyrimidines. By disrupting DNA synthesis and cell proliferation, Folsmart aims to suppress the immune cell activity that drives joint inflammation and destruction in patients with rheumatoid arthritis.

Brand names
Folsmart
Other names
Targeted liposomal methotrexate
02

Targets

FOLR1 (FRα)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on Folsmart.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folsmart.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call